
============================================================
                   AKTIENANALYSE: NOVN.SW                   
============================================================
Firmendaten werden abgerufen...
+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Novartis AG                  | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | Switzerland                  | Herkunftsland                |
+-------------+------------------------------+------------------------------+

Kurzbeschreibung: Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

Historische Daten werden abgerufen...
Historische Daten erfolgreich abgerufen.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            KURSVERLAUF VISUALISIERUNG            
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ASCII-ART KURSVERLAUF (Letzte 90 Tage)
Hoch: 99.78 | Tief: 82.96
--------------------------------------------------
                                                                                          
                         ******  ** *                                              *      
           *     * ** ***      **  * **                                        **** **    
 ***     **  **** *  *                                * *                   ***       ****
*    ****   *                                       ** * **         ********              
    *                                  *       *****       ****   **                      
                                         *   **                ***                        
                                        *                                                 
                                            *                                             
                                          **                                              
--------------------------------------------------
Datenpunkte: Jeder * reprÃ¤sentiert einen Tag
Nicht genÃ¼gend gemeinsame Datenpunkte fÃ¼r Performance-Vergleich im angegebenen Zeitraum (letzte 252 Handelstage).

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                TECHNISCHE ANALYSE                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $94.89  | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | -0.3%   | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $95.35  | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $92.59  | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $92.51  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 54.9    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $100.44 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $73.70  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 18.1%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
             FUNDAMENTALE KENNZAHLEN              
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $187,416,297,472.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 18.14               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | 15.35               | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 3.69%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 81.32               | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+

Bewertung der fundamentalen Kennzahlen:
- pe_ratio: Durchschnittlich
- dividend_yield: Gut (hohe Rendite)
- debt_to_equity: Schlecht (hohe Verschuldung)

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               ANALYSTENSCHÃ„TZUNGEN               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------+--------+------------------------------+
| Kategorie          | Wert   | ErlÃ¤uterung                  |
+====================+========+==============================+
| Analysten-Kursziel | $97.08 | Durchschnittliches Kursziel  |
+--------------------+--------+------------------------------+
| Upside-Potenzial   | 2.3%   | Potenzial fÃ¼r Kurssteigerung |
+--------------------+--------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            DCF SCHÃ„TZUNG & SZENARIEN             
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------------+------------+----------+---------------------------------------------+
| Szenario                 | DCF Wert   | Upside   | Annahmen                                    |
+==========================+============+==========+=============================================+
| Basis-Szenario           | $112.66    | 18.7%    | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Optimistisches Szenario  | $143.33    | 51.0%    | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Pessimistisches Szenario | $80.49     | -15.2%   | Annahmen: Wachstum 0.0%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               SENSITIVITÃ„TSANALYSE               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-----------------+----------------------+------------+
| Wachstumsrate   | Diskontierungsrate   | DCF Wert   |
+=================+======================+============+
| Wachstum 0.0%   | Diskontierung 0.1%   | $80.49     |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $103.48    |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $120.73    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $87.38     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $112.66    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $131.62    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $94.78     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $122.51    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $143.33    |
+-----------------+----------------------+------------+

==============================
Gesamtbewertung abgeschlossen 
==============================

+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Novartis AG                  | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | Switzerland                  | Herkunftsland                |
+-------------+------------------------------+------------------------------+
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $94.89  | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | -0.3%   | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $95.35  | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $92.59  | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $92.51  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 54.9    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $100.44 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $73.70  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 18.1%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $187,416,297,472.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 18.14               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | 15.35               | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 3.69%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 81.32               | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+
+--------------------+--------+------------------------------+
| Kategorie          | Wert   | ErlÃ¤uterung                  |
+====================+========+==============================+
| Analysten-Kursziel | $97.08 | Durchschnittliches Kursziel  |
+--------------------+--------+------------------------------+
| Upside-Potenzial   | 2.3%   | Potenzial fÃ¼r Kurssteigerung |
+--------------------+--------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
           AKTIENSTRATEGIE & EMPFEHLUNG           
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Kategorie         | Wert                                                                  | ErlÃ¤uterung                                |
+===================+=======================================================================+============================================+
| Kategorie         | Wert                                                                  | ErlÃ¤uterung                                |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Gesamtempfehlung  | ðŸŸ¡ Halten                                                              | Zusammenfassende Bewertung der Aktie.      |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| StÃ¤rken           | Hohe Dividendenrendite,                                               | Positive Aspekte der Analyse.              |
|                   | Geringe VolatilitÃ¤t                                                   |                                            |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| SchwÃ¤chen/Risiken | Hoher Verschuldungsgrad                                               | Negative Aspekte oder potenzielle Risiken. |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| BegrÃ¼ndung        | Forward P/E: 15.35, Dividende: 369.00%, DCF: 112.65842913411893 (EUR) | GrÃ¼nde fÃ¼r die Bewertung.                  |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Kaufzone          | 112.65842913411893 (EUR)                                              | Preisbereich fÃ¼r den Einstieg.             |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                DIVIDENDENWACHSTUM                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+---------------+-----------------+
| Kategorie     | Wert            |
+===============+=================+
| Jahr          | Dividende (EUR) |
+---------------+-----------------+
| 2016          | $2.21           |
+---------------+-----------------+
| 2017          | $2.25           |
+---------------+-----------------+
| 2018          | $2.29           |
+---------------+-----------------+
| 2019          | $2.33           |
+---------------+-----------------+
| 2020          | $2.41           |
+---------------+-----------------+
| 2021          | $2.45           |
+---------------+-----------------+
| 2022          | $2.53           |
+---------------+-----------------+
| 2023          | $2.62           |
+---------------+-----------------+
| 2024          | $2.70           |
+---------------+-----------------+
| 2025          | $2.86           |
+---------------+-----------------+
| Wachstumsrate | 2.93%           |
+---------------+-----------------+
Bewertung: Konstante und verlÃ¤ssliche Steigerung mit durchschnittlich 2.93% pro Jahr.
